Parkinson’s Disease Therapy ENERGI-F705PD Launch at BIO International 2025: Promising Treatment Unveiled by Energenesis Biomedical
Energenesis Biomedical to Showcase at BIO International Convention 2025 Energenesis Biomedical Co., Ltd. (TWSE: 6657), a biotechnology firm focused on developing treatments that restore cellular energy, has announced its participation in the upcoming BIO...
Read More